Endoscopic submucosal dissection in the treatment of patients with early colorectal carcinoma and precancerous lesions
- PMID: 33209487
- PMCID: PMC7657837
- DOI: 10.21037/jgo-20-393
Endoscopic submucosal dissection in the treatment of patients with early colorectal carcinoma and precancerous lesions
Abstract
Background: Our study aims to explore the indications and clinical efficacy of endoscopic submucosal dissection (ESD) on the early colorectal carcinoma and precancerous lesions.
Methods: The clinical data of 29 patients with early colorectal carcinoma and precancerous lesions who were treated with ESD at Nantong First People's Hospital between January 2018 and December 2019 were collected. Then the endoscopic morphology, postoperative pathological classification, tumor resection rate, postoperative complications, and follow-up outcomes were analyzed.
Results: Colorectal carcinoma lesions were distributed in the left colon, accounting for 89.6%. There were 14 cases (48.3%) with protuberant endoscopic tumors, accounting for the highest proportion, while 2 cases (6.9%) of the flat tumors, accounting for the lowest proportion. The average operation time for ESD was 123 minutes, and en-bloc resection was 100% while the curative resection rate was 89.6%. There were 3 cases (10.3%) with delayed hemorrhage after ESD, and 1 case with persistent hemorrhage during the operation was transferred to surgical treatment. No cases with infection or perforation after ESD. For postoperative pathological classification, villous-tubular adenoma with low-grade epithelioma accounted for 31%; tubular adenoma with high-grade epithelioma only accounted for 3.4%. There was no recurrence in the follow-up for 1-20 months.
Conclusions: Control of surgical indications strictly, improvement of operation skills, attention to postoperative pathological feedback, and close follow-up are necessary guarantees to improve the clinical effectiveness of ESD.
Keywords: Endoscopic submucosal dissection (ESD); clinical experience; early colorectal carcinoma and precancerous lesions.
2020 Journal of Gastrointestinal Oncology. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jgo-20-393). The authors have no conflicts of interest to declare.
Figures

Similar articles
-
Clinical efficacy of endoscopic submucosal dissection in the treatment of early esophageal cancer and precancerous lesions.J Cancer Res Ther. 2018 Jan;14(1):52-56. doi: 10.4103/jcrt.JCRT_805_17. J Cancer Res Ther. 2018. PMID: 29516959
-
[Pathological evaluation of endoscopic submucosal dissection for early gastric cancer and precancerous lesion in 411 cases].Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Apr 18;55(2):299-307. doi: 10.19723/j.issn.1671-167X.2023.02.014. Beijing Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37042141 Free PMC article. Chinese.
-
AGA Institute Clinical Practice Update: Endoscopic Submucosal Dissection in the United States.Clin Gastroenterol Hepatol. 2019 Jan;17(1):16-25.e1. doi: 10.1016/j.cgh.2018.07.041. Epub 2018 Aug 2. Clin Gastroenterol Hepatol. 2019. PMID: 30077787 Review.
-
Long-term outcomes of endoscopic submucosal dissection for high-grade dysplasia and early-stage carcinoma in the colorectum.Cancer Commun (Lond). 2018 Mar 21;38(1):3. doi: 10.1186/s40880-018-0273-4. Cancer Commun (Lond). 2018. PMID: 29764504 Free PMC article.
-
Endoscopic Submucosal Dissection (ESD) in Colorectal Tumors.Viszeralmedizin. 2014 Feb;30(1):39-44. doi: 10.1159/000358529. Viszeralmedizin. 2014. PMID: 26288580 Free PMC article. Review.
Cited by
-
Construction and analysis of an ulcer risk prediction model after endoscopic submucosal dissection for early gastric cancer.World J Gastrointest Oncol. 2022 Sep 15;14(9):1823-1832. doi: 10.4251/wjgo.v14.i9.1823. World J Gastrointest Oncol. 2022. PMID: 36187385 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous